Shanghai Pharmaceuticals buys out Cardinal Health in China to become top distributor of imported drugs

After deducting amounts owed to its original shareholders and debt holders, and other accounting adjustments, the amount Shanghai Pharmaceuticals Holding will pay to fully buyout Cardinal’s China business is US$557 million. The acquisition will help …
( read original story …)